Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban In Atrial Fibrillation Patients Treated With Left Atrial Appendage Closure

NCT03273322 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

105

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation
Atrial Appendage
Hemorrhage

Interventions

DRUG: Rivaroxaban 10 mg qd
DRUG: Rivaroxaban 15 mg qd
DRUG: DAPT

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]
[object Object]